在SIRPβ1内的插入显示了对阿尔茨海默氏症认知衰退的双重效应,改变了微质反应
José María García-Alberca1, Itziar de Rojas2,3, Elisabeth Sanchez-Mejias3,4
1Alzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
Journal of Alzheimer's disease : JAD
|March 1, 2024
概括
一种SIRPβ1的结构变异通过改变粉样蛋白β (Aβ) 清除和微质激活,影响阿尔茨海默病 (AD). 这一发现可能会为针对AD中TREM2-TYROBP途径的治疗策略提供信息.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 微质功能障碍是阿尔茨海默病 (AD) 发病的一个关键因素.
- 这项研究研究了一种SIRPβ1的特定生殖系变体,SIRPβ1是一种通过TYROBP对粉样蛋白β (Aβ) 细胞消化至关重要的受体.
研究的目的:
- 为了确定SIRPβ1中的副本数变异对其表达的影响.
- 分析这种变异如何影响AD的基础分子机制.
主要方法:
- 在纵向队列中评估的副本数变异代理 rs2209313 (GERALD,GR@ACE).
- 检查了基因型的AD患者的海马体样本.
- 在HEK393T细胞中进行SIRPβ1异型特异性细胞分析.
主要成果:
- 这种SIRPβ1插入变体改变了蛋白质异型,损害了Aβ结合和TYROBP相互作用.
- 患有SIRPβ1重复 (Dup/Dup) 患者的CSF t-Tau/Aβ比率增加,AD风险更高.
- 杜普/杜普患者表现出较慢的认知衰退和减少的海马变性,尽管最初对AD的反应更差.
- 重复的等位基因与更高的TREM2表达和增加的微质激活相关.
结论:
- SIRPβ1的内部重复对阿尔茨海默氏症的进展和MCI转化为痴呆症有双重影响,影响微质对Aβ的反应.
- 这种SIRPβ1变体可能是TREM2-TYROBP通路的潜在调节器,与AD药物治疗有关.
相关概念视频
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


